EXOMIND in Tampa: What This TMS Treatment Is and How It Works

EXOMIND is a device made by BTL, a medical equipment manufacturer. According to BTL, EXOMIND is cleared by the FDA for the treatment of major depressive disorder. It belongs to a category of care called transcranial magnetic stimulation, or TMS. The category itself is not new: the FDA cleared the first TMS device for depression in 2008, and TMS has been part of mainstream depression care in the United States ever since.

If you have searched for EXOMIND in Tampa and found very little written in plain English, that is normal. The device is newer to the market than the clinical TMS systems used in psychiatric settings, and much of what exists online is promotional. This article takes the opposite approach. It explains what the treatment is, what a session involves, who should be screened out, and when a different path makes more sense.

Neuromag Institute offers this treatment as part of a neurology practice on N. Armenia Avenue in Tampa, led by Dr. Jairo D. Libreros, MD, a board-certified neurologist who has practiced in Tampa for about 30 years. You can see how the practice presents the treatment on the EXOMIND page. This article covers the background in more depth.

TMS rests on a simple principle of physics: a changing magnetic field can create a small electrical current in nearby tissue. A TMS device holds an electromagnetic coil close to the scalp. The coil delivers brief magnetic pulses that pass through the skull without cuts or injections and produce tiny currents in the outermost layer of the brain.

Those pulses are aimed at regions involved in mood regulation, most often an area of the prefrontal cortex, behind the forehead. In depression, activity in these mood circuits is often reduced. The idea behind TMS, built up over years of clinical use, is that repeated stimulation over a course of sessions encourages those circuits to work more normally.

Two points separate this from older ideas people sometimes associate with brain stimulation. First, TMS is noninvasive: nothing is implanted and no surgery is involved. Second, it requires no anesthesia. Patients are awake, seated, and able to drive themselves home afterward. All of this is standard, widely published information about the TMS category.

This is the question most people actually want answered, and it deserves a two-part reply. The first part is about the category. TMS is an established treatment for major depressive disorder, not an experimental one. Devices in this family have held FDA clearance since 2008, and TMS is an accepted part of psychiatric practice across the country, particularly for depression that has not improved enough with medication.

The second part is about this specific device. BTL, the manufacturer, reports that EXOMIND holds FDA clearance for major depressive disorder. What no honest clinic can tell you is exactly how you, personally, will respond. Response to any depression treatment varies from person to person, whether that treatment is medication, talk therapy, or stimulation. Anyone promising a specific result is overselling.

So the fair summary is this: the science behind the category is established, the device is FDA-cleared for depression, and the right expectation is a cautious, individual one. A careful evaluation before starting matters more than anything written in an advertisement.

A session looks like an ordinary office visit. You sit in a chair, awake, in your regular clothes. A trained staff member positions the device against your head, and when treatment begins most people describe a tapping or knocking sensation on the scalp along with a clicking sound from the coil.

Sessions are short. Treatments in the TMS family are measured in minutes, not hours, and there is no sedation, no recovery room, and no downtime. Most people go straight back to work, driving, and daily routines. Treatment is delivered as a series of visits scheduled over a period of weeks, and the exact number and spacing depend on the individual plan.

Side effects, when they occur, are usually mild. The most commonly reported for the TMS category are scalp discomfort at the treatment site and a mild headache that fades after the session. Serious effects are rare, and careful screening beforehand is one of the main reasons they stay rare.

TMS-family devices use strong magnetic fields, so screening starts with metal. As a general rule, this treatment is not appropriate for people with:

The seizure point deserves a plain explanation. Magnetic stimulation of the brain carries a small risk of triggering a seizure. That risk is low, and screening exists precisely to keep it low. A history of head injury, certain medications, and some neurological conditions all belong in the conversation before treatment is ever scheduled.

This is where being evaluated at a neurology practice is a practical advantage. Dr. Libreros evaluates seizure disorders, brain injury, and other neurological conditions as part of his everyday clinical work, so the screening questions that matter for TMS are questions this practice already asks all day. You can read more about him and the practice on the about page.

An honest explainer has to say this clearly: EXOMIND is not the right answer for everyone with depression, and it is not a replacement for psychiatric care. If your depression has not responded to several medications, a formal course of clinical TMS prescribed through a psychiatrist may be the more appropriate route, and insurance often covers those courses for treatment-resistant depression. For other people, the simpler and better step is an adjustment in medication or therapy, made with the clinician who already knows them.

Where Neuromag Institute fits is in helping sort this out. A neurological evaluation can look at the whole picture: mood symptoms, memory concerns, headaches, sleep, current medications, and any neurological conditions that may be part of the story. From there, the honest options can be laid out, which may include EXOMIND, a referral toward psychiatric care, or both working together. To ask whether an evaluation makes sense for you, contact the office and the staff will help you set it up.